Therefore we evaluated the relationship between highly frequent mutations and two survival factors progression-free survival or overall survival

To evaluate the relationship between highly frequent mutations and progression-free survival or overall survival, we conducted a retrospective analysis on a cohort of patients. The cohort consisted of individuals with a specific disease or condition for which the mutations were known to be relevant.

We collected data on the presence or absence of highly frequent mutations in each patient's genetic profile. These mutations were determined through genetic testing or sequencing techniques. We also recorded the patients' progression-free survival and overall survival times from the time of diagnosis or treatment initiation.

Using statistical analysis methods, we assessed the association between the presence of highly frequent mutations and the patients' survival outcomes. We compared the survival times of patients with and without these mutations using survival analysis techniques such as Kaplan-Meier curves and Cox proportional hazards models.

The findings of our analysis revealed whether the presence of highly frequent mutations was associated with significant differences in progression-free survival or overall survival. This information can provide insights into the prognostic value of these mutations and their potential implications for personalized treatment strategies.

It is important to note that our analysis may have certain limitations, such as potential confounding factors or biases inherent in retrospective studies. Therefore, further research and validation studies are necessary to confirm and generalize our findings